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1. Introduction 
Probiotics are defined as viable microorganisms that exhibit beneficial effects on the health 
of the host [1]. Now, probiotics are known to possess physiological functions such as 
inhibition to pathogens, assisting digestion, immunoregulatory activity and antitumor 
activity [2]. Here, we discuss the effects of probiotic on lipid metabolism from seven main 
aspects including history, antioxidant effect, impact on lipoprotein, microflora view, 
hormones, receptors and new mechanisms. 
1.1. Past and present 
As early as in 1974, Mann and Spoerry observed that inhabitants from African Maasai tribes 
maintained a lower level of blood lipids due to a high fermented milk intake [3]. Further 
perspective suspected that live Lactobacilli included in fermented milk may contribute to 
reducing cholesterol [4]. The cholesterol-reducing effect of probiotic has become more 
apparent with the discovery of bile salt deconjugating and cholesterol assimilating ability of 
Lactobacillus  [5] [6]. Thereafter, a set of screening procedures both in vitro and vivo was 
established for evaluation of cholesterol-reducing probiotics [7]. Many probiotic strains 
mostly L. acidophilus were screened out with cholesterol-reducing property [8].  
A new study by Lye et al showed that there existed five possible probiotic mechanisms 
including assimilation of cholesterol during growth, binding of cholesterol to cellular 
surface, disruption of cholesterol micelle, deconjugation of bile salt and bile salt hydrolase 
(BSH) activity [9]. Now with the development of molecular biology, we can judge 
cholesterol-lowering effect firstly by detection of BSH gene and its expression in a probiotic 
genome. A recent study by Sridevi et al showed that Lactobacillus buchneri ATCC 4005 
exhibited a great cholesterol-lowering property through an optimal condition of bile salt 
hydrolase production [10]. In conclusion from a meta-analysis, administration of probiotic 
can exect benefits on total cholesterol and LDL-cholesterol level of human [11].  
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There are some reports that fermented soy milk by probiotics also showed favorable 
function of regulating lipids level [12]. The advantages of fermented soy milk are that 
undesirable soybean oligosaccharides can be hydrolysed which provide nutritional 
components for probiotic and a large variety of peptides and amino acids are produced as 
well as active aglycon form of isoflavones [13]. An improved cholesterol profile was 
observed with daily intake of a probiotic soy product [14]. It seems possible that living 
probiotics and functional isoflavones cooperated in regulating lipid profile. 
2. Antioxidant effect 
Probiotic originated from longevity research by the well-known Eli Metchnikoff. As we all 
known, various published evidence suggested reduction of oxidative stress led to longevity-
promoting consistent with Harman's Free Radical Theory of Aging [15]. These two 
observations inspired the investigation of antioxidant ability of probiotics. 
Oxidative stress induced by obesity tend to produce surplus reactive oxygen species (ROS) 
which may cause further damage by free radical chain reaction mechanism [16]. ROS have 
some deleterious effects on polyunsaturated lipids in cell membrane leading to damage of 
cell structure and malondialdehyde (MDA), which was also toxic to DNA and protein and 
formed as a marker of lipid peroxidation at the same time [17] [18]. As for the oxidative 
stress, human body has its own antioxidant defense system including superoxide dismutase 
(SOD), catalase (CAT), glutathione peroxidase (GSH-Px) , glutathione (GSH) and so on [19]. 
Many Lactobacillus strains with antioxidative effects were not only reducing MDA level, but 
also enhance the antioxidants production (Table1). 
 
Strains Model Antioxidant effects Renferences 
Probiotic yoghurt 
containing Lactobacillus 
acidophilus La5 
and Bifidobacterium 
lactis Bb12 
Type 2 
diabetic 
patients 
Serum MDA concentration 
significantly decreased 
[20] 
Probiotic yoghurt containing 
Lactobacillus 
acidophilus LA-5 and 
Bifidobacterium BB-12 
Pregnant 
Women 
Increased erythrocyte 
glutathione reductase levels, 
plasma glutathione and 8-oxo-
7,8-dihydroguanine  levels 
[21] 
Lactobacillus casei Zhang 
High-fat fed 
rat 
A decrease of MDA and 
increase of SOD and GSH-Px 
in serum and liver 
[22] 
Lactobacillus fermentum pigs 
Increased total antioxidant 
capacity, SOD and GSH-Px 
activity in serum as well as 
hepatic CAT and muscle SOD;
Decreased MDA level in serum 
and muscle 
[23] 
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Strains Model Antioxidant effects Renferences 
Probiotic yoghurt containing 
Lactobacillus 
acidophilus LA-5 and 
Bifidobacterium BB-12 
human 
An increase of SOD and 
catalase activity 
[24] 
Bacillus polyfermenticus 
Rats with 
colon 
carcinoge-
nesis 
Lower plasma lipid 
peroxidation levels and higher 
plasma total antioxidant levels
[25] 
Probiotic dahi containing 
Lactobacillus acidophilus and 
Lactobacillus casei 
High fructose 
fed rats 
Lower values of TBARS and 
higher values of glutathione in 
liver and pancreatic tissues 
[26] 
Lactobacillus fermentum ME-3 human 
Enhanced total antioxidative
status
[27] 
Bacillus polyfermenticus SCD
High-Fat and 
cholestero-l 
fed rat 
An increase in total radical 
trapping antioxidant potential 
(TRAP) and a decrease in 
conjugated dienes in plasma
[28] 
Streptococcus thermophilus 
YIT 2001 
Iron 
overloade-d 
mice 
A significant decrease of lipid 
peroxide in the colonic mucosa
[29] 
VSL#3 ob/ob mice 
Lower fatty acid beta-
oxidation
[30] 
L. acidophilus rats 
Higher GSH-Px activity in red 
blood cells
[31] 
L .rhamnosus SBT 2257 rats 
Inhibition of hemolysis of  red 
blood cell under the condition 
of vitamin E dificient
[32] 
Table 1. Antioxidative effects of probiotics 
3. Impact on lipoprotein  
Lipoprotein transport play an important role in accumulation of host lipopolysaccharide 
level (LPS) [33]. Studies by Cani et al showed that elevated LPS level was considered as a 
trigger factor involved in the pathogenesis of obesity and metabolic risk via innate immune 
mechanism [34]. LPS-binding protein (LBP) and lipoproteins exert a synergistic effect on 
reducing the toxic LPS level[35].  
Several fermented milk containing probiotics were demonstrated to reduce low-density 
lipoprotein cholesterol(LDL-c) level and very-low-density lipoprotein cholesterol (VLDL-c) 
in animal and human [26] [36] [37].Recently, L. casei Shirota had been proved a plasma LBP-
lowering effect in obesity mice and L. reuteri NCIMB 30242 yoghurt could improve ApoB-
100 level in hypercholesterolaemic subjects, suggesting that probiotic possess LPS-reducing 
function to delay the obesity risk [38] [39]. 
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4. The whole microflora view 
Intestinal microbes not only Lactobacillus could also exhibit a bile salt deconjugating effect 
[40], suggesting that other microbes had lipid-reducing potential. Thus, overall intestinal 
microflora was taken into account for lipid metabolism evaluation. In the past few years, 
research has focused on new areas of microflora and lipid metabolism with the development 
of culture-independent methods for understanding the total microbial diversity [41].  
The human gut is consisting of a microbial community of 1014 bacteria with at least 1000 
species and the whole microbiome is more than 100-fold the human genome [42].These 
researches highlight the significance of the whole gut microbiome contribute to energy 
harvest and the relationship between obesity and changes of gut microbiome [43]. More 
detailed, obese is mainly characterized by elevated Firmicutes/Bacteroidetes ratio in gut [44]. 
Probiotics serve as one of effective agents for regulation of gut microflora, they can exext 
benefits on lipid metabolism through downregulating the ratio of Firmicutes/Bacteroidetes. 
Other bacteria such as Methanobrevibacter smithii are also at low level in obese people [45]. 
Interestingly, atherosclerotic disease, which caused by accumulation of cholesterol and 
inflammation, was recently found its atherosclerotic plaque microbiota was associated with 
oral and gut microbiota through high throughput 454 pyrosequencing of 16S rRNA genes [46]. 
Besides, such a huge microflora provide a large reservoir of LPS molecules to circulation 
through colonizing of Gram-negative bacteria in the gut [47]. A recent study showed 
Bifidobacteria with genes encoding an ATP-binding-cassette-type carbohydrate transporter 
could protect against Gram-negative E. coli O157:H7 colonization in gut due to acetate 
production [48]. Thus, probiotic can restrict LPS-related microbial communities in the gut.  
The whole gut microflora is also known as a target for drug metabolism because of diverse 
microbial transformations [49]. Manipulation of commensal microbial composition through 
antibiotics, probiotics or prebiotics was thought to enhance the metabolic activity and 
production of effective metabolites [50]. Simvastatin, which is an inhibitor of HMG-CoA and 
widely used for regulating hepatic cholesterol production, was proposed to possess altered 
pharmacological properties by microflora degradation via changing its capacity to bind to 
the corresponding receptors [51]. It is indicated that probiotics have potential to influence 
the metabolism of lipid-regulating drugs in gut. 
5. Regulation of leptin, adiponectin and osteocalcin 
Hormones such as leptin, adiponectin and osteocalcin play an important role in lipid 
metabolism. Obese population was characterized by significant lower levels of osteocalcin 
and adiponectin as well as high leptin level (leptin-resistant) which have been reported in 
literature. It is now increasingly accepted that leptin can regulate food intake and energy 
expenditure through hypothalamus and adiponectin can enhance tissue fat oxidation to 
downstream fatty acids levels and tissue triglyceride content associated with insulin 
sensitivity [52]. As for osteocalcin, leptin assumed to modulate osteocalcin bioactivity and 
osteocalcin could stimulate the adiponectin synthesis [53] [54]. 
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5.1. Leptin 
Leptin, an antiobesity hormone produced by adipose tissue, has been reported to regulate 
body weight by controlling food intake and energy expenditure [55]. However, obesity tend 
to display markedly higher serum leptin level with a leptin-resistant symptom. Several 
studies reported a decrease of leptin by probiotic administration. In high-fat fed mice, Lee et 
al  confirmed that Lactobacillus rhamnosus PL60 exhibited a reduction in leptin level and anti-
obesity effect due to production of conjugated linoleic acid [56]. Moreover, serum leptin 
concentration was reduced by Lactobacillus gasseri SBT205 in lean Zucker rats linked with 
lowered adipocyte size [57]. Another study also report leptin level was reduced by a 
combined bifidobacteria (B. pseudocatenulatum SPM 1204, B. longum SPM 1205, and B. longum 
SPM 1207) in obese rats [58]. Interestingly and controversially, direct injection of 
Lactobacillus acidophilus supernatants (germ free) into the brains of rats lead to weight loss 
with an increase in leptin expression in neurons and adipose tissue [59]. 
Leptin-lowering effect of probiotics was also observed in human. Similarly, Naruszewicz et 
al investigated whether oral administration of L. plantarum 299v exert beneficial effect on 
smokers by detection of cardiovascular risk factors [60]. In this study, smokers showed a great 
decrease in plasma leptin concentrations and anti-inflammatory properties when supplement 
of probiotic. Discouragingly,  two months of Lactobacillus acidophilus and Bifidobacterium longum 
consumption failed to lower plasma leptin levels in male equol excretors [61]. 
5.2. Adiponectin 
As an adipocyte-derived serum protein, adiponectin play an important role in glucose and 
lipid metabolism since adiponectin deficiency are associated with insulin resistance, 
inflammation, dyslipidemia and risk of atherogenic vascular disease [62]. In parallel, 
adiponectin has also been shown to suppress macrophage foam cell formation in 
atherosclerosis [63]. Several studies showed that probiotic therapy improved adiponectin 
level or adiponectin gene expression. One comparative research performed in normal 
microflora (NMF) and germ-free (GF) mice revealed that adiponectin gene expression 
(Adipoq) was up-regulated in the groups of Lactobacillus-treated germ free mice [64]. 
Moreover, Higurashi et al reported a probiotic cheese could prevent abdominal adipose 
accumulation and maintained serum adiponectin concentrations in high-calorie fed rats [65]. 
However, Lactobacillus plantarum strain No. 14 exert a white adipose-reducing effect in high-
fat fed mice with no change of adiponectin [66].  
Kadooka et al used a probiotic L. gasseri SBT2055 to regulate abdominal adiposity in obese 
adults, where the probiotic treatment involved a significant reduction in abdominal visceral 
and subcutaneous fat areas from baseline and significantly increased high-molecular weight 
adiponectin in their serum [67]. Furthermore, a recent large scale clinical study conducted 
by Luoto et al confirmed that pregnant women with a consumption of combined 
Lactobacillus rhamnosus GG and Bifidobacterium lactis probiotics possessed higher colostrum 
adiponectin concentration compared to placebo which was correlated inversely with 
maternal weight gain during pregnancy [68]. 
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5.3. Osteocalcin 
In recent years, osteocalcin secreted by osteoblasts has aroused great interest linked to β cell 
function, adiponectin production, energy expenditure and adiposity [69]. In humans, fat 
individuals kept a low level of serum osteocalcin [70]. The only study by Naughton et al  
showed that osteocalcin levels was slightly increased in middle aged rats by consumption of 
inulin-rich milk fermented by Lactobacillus GG and Bifidobacterium lactis [71]. It is interesting 
that osteocalcin is an vitamin K-dependent protein and two main types including vitamin 
K1 and vitamin K2 are respectively produced from dietary vegetable and microflora [72]. As 
an effective way to alter microflora, probiotics have potential to enhance vitamin K2 
production and related osteocalcin level through changing the microflora. 
6. Interaction with receptors 
Various Receptors are involved in regulating important genes in lipid transport and 
metabolism and selected as potential therapeutic targets for dyslipidemia and 
atherosclerosis. Recent studies have focused on nuclear receptors (NRs), G protein-coupled 
receptor (GPRs) and Toll-like receptors (TLRs) as factors regulated by probiotics 
administration. But the crosstalk among NRs,TLRs and GPRs have not been clearly 
elucidated. The only investigation about crosstalk of NRs,TLRs and microflora between 
specific pathogen-free (SPF) mice and germ-free (GF) mice have revealed that LXR alpha, 
ROR gamma and CAR expression were reduced while TLR-2 and TLR-5 increased in SPF 
compared with GF mice [73]. 
6.1. Nuclear receptors 
According to the stated above, some probiotics were found to be effective in reducing blood 
cholesterol level and one possible mechanism is enhanced fecal bile acids level. As one of 
important lipid mediators, bile acids have been confirmed to influence a series of NRs 
including farnesoid X receptor (FXR), pregnane-X-receptor (PXR), constitutive androstane 
receptor (CAR), peroxisome proliferator-activated receptor (PPAR), liver X receptor (LXR), 
glucocorticoid receptor(GR) and vitamin D receptor(VDR) [74-76].  
Recently, Lactobacillus acidophilus ATCC 4356 could act as a liver X receptor (LXR) receptor 
agonist and inhibited the cellular uptake of micellar cholesterol in Caco-2 cells [77]. A 
similar study conducted with Yoon et al using a combination of L. rhamnosus BFE5264 and L. 
plantarum NR74 also showed a up-regulating the expression of LXR and promotion of 
cholesterol efflux in Caco-2 cells [78]. This is identical to effect of bile acid sequestrants drug 
which can also induce an increase of LXR activity in liver[79]. 
As we all known, PPARs play a key role in inflammation and blood glucose metabolism. 
Some studies have indicated that probiotic regulated the expression of PPARs in 
experimetal inflammatory model [80]. In fact, PPARs is also a target gene of energy 
homeostasis and adipogenesis [81]. Linked to ApoE gene transcription, PPAR-γ need LXR 
pathway for regulating adipocyte triglyceride balance [82]. Avella et al reported that dietary 
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probiotics could modify the expression of PPAR-α, PPAR-β, VDR-α, RAR-γand GR in a 
marine fish, suggesting extensive crosstalk among NRs activated by probiotic [83]. 
Concerning about NRs and lipid metabolism linked with probiotic, Aronsson et al observed 
that L. paracasei F19 could reduce the fat storage associated with the drastic changes of 
PPARs [84]. One most recent study by Zhao et al have also demonstrated probiotic 
Pediococcus pentosaceus LP28 could also acted as a PPAR-γ agonist concomitantly with the 
great reduction of triglyceride and cholesterol in obese mice [85]. 
6.2. Toll-like receptors 
As important pattern recognition receptors, TLRs participate in distinguishing and 
recognizing a range of microbial components such as peptidoglycan (TLR2) and LPS (TLR4) 
to activiate immune responses [86]. Up to date, the relationship between TLRs and lipid 
metabolism is mainly from two aspects. On one hand,TLRs signaling can directly contact 
and interfere with cholesterol metabolism in macrophages [87]. On the other hand, TLRs 
signaling (mainly TLR4) are involved in interaction LPS with fatty acid, lipoprotein and 
organ injury(especially liver and intestine). There is evidence that low dose of LPS can boost 
de novo fatty acid synthesis and lipolysis and lipoprotein production in liver which leading 
to hepatic hypertriglyceridemia [88]. In mice, moderately higher LPS level could be 
increased by a fat-enriched diet and contributed to low grade inflammation [34]. In rabbits, 
high cholesterol intake plus with low dose LPS accelerated the development of 
atherosclerosis [89]. These two studies are considered as the result of crosstalk between LPS 
and TLRs leads to intestinal mucosal injury associated with inflammatory response. Besides, 
foam cell formation in atherosclerosis has been shown to be mediated by TLR2 and 4 and 
other TLRs such as TLR3, 7, and 9 may also participate in atherosclerosis [90] [91]. 
TLR4 appears to be tightly linked to high-fat intake, LPS and inflammation. Probiotics are 
known to reduced LPS-containing gram-negative organisms (such as E. coli) in the gut and 
influx of LPS into circulation [92] [93]. A great number of probiotics are also able to 
specifically modulate the NF-κB pathway (one of most important inflammatory pathways)in 
intestinal epithelial cells and macrophages [94].  
Due to TLR4 deficiency with anti-obesigenic effects and susceptible to colitis, little 
information about influence of probiotic on lipid metabolism is obtained in TLR4 knockout 
model whereas protective effect of probiotic VSL#3 from inflammation was observed in 
TLR4 knockout mice [95] [96]. With regard to the role of TLR4 in the development of 
metabolic disorders, Andreasen et al have considered that L. acidophilus NCFM may reduce 
overflow of LPS from the gut to the circulation and downregulate the TLR4 signalling and 
pro-inflammatory cytokines in human subjects [97]. 
Immunity homeostasis also have important effect on lipid metabolism. In general, it is well 
accepted that probiotic bacteria are able to maintain the Th1 and Th2 banlance of immunity 
through regulating pro-inflammatory and anti-inflammatory cytokines [98]. In addition, 
Agrawal et al documented that TLR2-derived signaling mainly enhance Th2-cytokine 
release, while TLR4 triggered by LPS stimulates Th1-type responses [99]. Interestingly, 
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Voltan et al found that L. crispatus M247 could increase TLR2 mRNA level and reduced 
TLR4 mRNA and protein levels in the colonic mucosa, suggesting that L. crispatus M247 
maintain the Th1 / Th2 homeostasis through TLR2 / TLR4 banlance [100]. 
6.3. G protein-coupled receptors 
It has been well-established that probiotic bacteria exert beneficial effects on the intestine 
especially the antimicrobial property by producing organic acids or regulating the organic 
acid-producing flora [93]. It has been also reported that GPR41 and GPR43 can be activated 
by short-chain fatty acids(SCFAs)[101]. Thus, it is possible that probiotic may affect GPRs 
through production of SCFAs in gut. However, this relationship among these have not yet 
been well-established. Study performed in Gpr41-deficient mice under germ free or 
conventional environment revealed that present of microflora was associated with harvest 
of short-chain fatty acids from the diet which control the degree of adiposity [102]. 
By our knowledge, only one study has investigated the effect of prebiotic which can 
specifically increase intestinal probiotic bifidobacteria on GPR43 expression through 
modified lipid profile [103]. Using a high-fat fed rodent model, the authors studied the 
effects of prebiotic on changes of microflora, adipose fatty acid profile and receptors 
expression. High fat diet is able to increase GPR43 and TLR4 expression as well as PPAR-γ 
expression due to oleic acid and α-linolenic acid production, while prebiotic decreases 
GPR43 and TLR4 overexpression. 
7. New mechanisms exploration 
In the past recent years, new mechanisms of probiotics on lipid metabolism were proposed. 
A research by Khedara et al showed lower nitric oxide level has been responsible for 
hyperlipidemia since endogenous nitric oxide can reduce fatty acid oxidation [104]. Some 
probiotics had ability to induce nitric oxide synthesis through activation of inducible nitric 
oxide synthase [105] [106]. Thus, modified NO availability by probiotics play an important 
role in lipid metabolism.  
Moreover, Tanida et al demonstrated that Lactobacillus paracasei ST11 could increase adipose 
tissue  lipolysis through enhancing the autonomic nerve activity [107]. In liver, probiotics 
also exhibited lipid-reducing effects [108]. Ma et al demostrated that VSL#3 probiotics could 
increase hepatic NKT cell numbers to attenuate high fat diet-induced steatosis [109]. Huang 
et al found that L. acidophilus 4356 could downregulate the Niemann-Pick C1-Like 1 
(NPC1L1) level in the duodenum and jejunum of high-fat fed rats [110]. Another recent 
study by Aronsson et al revealed a new mechanism of Lactobacillus paracasei F19 to reduce fat 
storage by up-regulating levels of Angiopoietin-Like 4 Protein (ANGPTL4) in mice [84]. 
Omics technology provide a new insight into the mechanisms of lipid metabolism 
influenced by probiotics. Lee et al demostrated that gene ccpA (encodes catabolite control 
protein A) had function in cholesterol reduction in vivo by comparation of cholesterol-
reducing strain L. acidophilus A4 and the BA9 mutant strain with no lipid-lowering effect 
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[111]. In addition, six main different expressed proteins involved in these two different 
strains in vitro were identified by proteomic analysis including transcription regulator, 
FMN-binding protein, major facilitator superfamily permease, glycogen phosphorylase, 
YknV protein, and fructose/tagatose bisphosphate aldolase. 
Microarray analysis of probiotic L. casei Zhang effect on liver of high fat diet-fed rats 
revealed that L. casei Zhang administration promote the β-oxidation of fatty acid metabolism 
through up-regulating five genes expression (Acsl1, Hadh, Acaa2, Acads, and gcdH). 
Moreover, L. casei Zhang could strongly activate expression of glucocorticoid receptor 
(NR3C1 gene) which might be related to protect against high-fat induced low grade 
inflammation [112]. 
Recently, small intestinal proteomes in weanling piglets that respond differently to probiotic 
(Lactobacillus fermentum I5007) and antibiotic (Aureomycin) supplementation in terms of 
lipid metabolism have shown that probiotic enhanced mucosal SAR1B abundance could 
prevent weanling piglets from fat malabsorption. More importantly, high mucosal 
abundance of EIF4A and KRT10 in probiotic-treated piglets may contribute to improve 
overall gut integrity, suggesting a potential reduction of LPS influx [113]. 
8. Conclusion 
In conclusion, probiotic is a better prevention and treatment strategy for regulating lipid 
homeostasis with the high prevalence of obesity, burden of amazing overweight and 
developing chronic diseases in the modern world. Despite the fact that people too pay 
attention to the thin result to neglect the drug side effect, probiotic can avoid this to achieve 
a healthy weight. Enhancing bile acids enflux and gut cholesterol assimilation was 
considered as the classic theory for cholesterol-reducing probiotics. Nevertheless, rencent 
studies focus on antioxidant activity and interaction with lipoprotein, hormones and the 
whole microbiota.  Besides, crosstalk among NRs, GPRs and TLRs by probiotics is new 
frontiers for mechanical research. However, further investigations are needed to identify 
various responses related to lipid metabolism influenced by probiotics. 
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